common glp-1 agonists Receptor Agonists: An Alternative for Rapid-Acting Insulin? Frontiers | Glucagon-like peptide-1 receptor
Description
A new study finds that popular GLP-1 drugs used to treat diabetes and obesity show new promise in fighting multiple substance use disorders.
- Mechanism of Action & Protocol.
Consultancy sees the active GLP-1 user population rising by as much as 50% by 2027.
GLP-1 Agonists for Obesity in Non-Diabetic Patients: Game Changer or Overhyped
However, there was no significant difference in adverse CVEs or all-cause mortality when compared with those taking SGLT2 inhibitors
A new GLP-1 oral medication from AstraZeneca, known as elecoglipron, lowered blood sugar levels and led to 10.5% weight loss in a phase 2b clinical trial.
